Show menu

Latest news from SEQENS Group

Lorem ipsum dolor sit amet consectetur. Eu justo in urna scelerisque venenatis faucibus felis at dui. Et eu quam leo vestibulum. Nulla feugiat quis imperdiet eu gravida sit aliquam tellus proin. Ipsum quis dui duis vel vulputate. Eget quisque morbi pretium facilisi. Malesuada velit faucibus eget at quisque ultrices. Quis tortor auctor eget mauris nibh tincidunt purus tortor.

Enim nisi neque id magna volutpat pellentesque phasellus diam urna. Risus ipsum non sodales sed ac quis. Donec ultricies iaculis eleifend aliquam ut. Purus nisl parturient venenatis enim sapien tellus adipiscing lorem viverra. Blandit dolor penatibus montes erat ut bibendum velit. Sodales dui egestas sit pharetra. Turpis vitae sit integer eget lobortis. Tellus nunc morbi rhoncus cursus nisi gravida lorem. Sit mi tortor auctor ut. Condimentum lacus tortor odio arcu sagittis nullam venenatis. Mauris bibendum lacinia id tempor amet pellentesque nunc. Mollis aliquam commodo massa elementum venenatis tortor pulvinar quam eu. Quam quis semper massa vitae fringilla semper. Vulputate euismod ultrices tempor egestas nibh eget.

image
SEQENS announces the appointement of a new CEO
France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued
Read more
image
Labcom HitCat Inauguration in partnership with the CNRS
Read more
image
France Relance program: SEQENS new paracetamol production unit
Read more
image
Professor Patrick Couvreur joins the Seqens Scientific Council
Read more
image
3rd Franco-German Technology Dialogue
Read more
image
Essential molecules’ production in France: our investment plan
Read more
image
Seqens’ commitment to reducing its carbon footprint
Read more
image
New collaboration between SEQENS and RONDOL
Read more
image
SEQENS and Rondol Group: a new collaboration in formulation research
Read more
image
Safety by design ® : a new approach to toxicological risk management
Read more
image
Decarbonization: SEQENS becomes a reference for the industry
Read more
image
A new 45,000 tons ISOPROPANOL production facility
Read more
image
Essential molecules: SEQENS invests in new technologies
Read more
1 2 3